Literature DB >> 18680168

Elucidation of two major aggregation pathways in an IgG2 antibody.

Nicholas Van Buren1, Douglas Rehder, Himanshu Gadgil, Masazumi Matsumura, Jaby Jacob.   

Abstract

Two major aggregation pathways observed in an IgG2 molecule are described. Different aggregate species generated by long-term incubation of the antibody at 37 degrees C were collected by a semi-preparative size exclusion chromatography method. These purified species were analyzed extensively by denaturing size-exclusion chromatography methods. The major aggregation pathway at low pH (4.0) resulted in the formation of both dimers and high molecular weight (HMW) aggregates. It was found that these dimers and HMW aggregates contain antibody molecules that have a peptide bond cleavage between an aspartic acid and proline residue in the CH2 domain. Evidence that unfolding of the CH2 domain may be driving the aggregation at low pH is presented. At higher pH (pH - 6.0), formation of a dimer having approximately 75% covalent character was the major aggregation pathway while formation of higher molecular weight aggregates were largely suppressed. The covalent dimer consisted of both disulfide linked antibody molecules and another species (approximately 26%) that was formed due to nondisulfide covalent bonds between two heavy chains. At pH - 5.0, both dimer and higher molecular weight aggregates were formed and the aggregation pathway was a combination of the major pathways observed at pH - 4.0 and 6.0. The dimer species formed at pH - 5.0 had a larger contribution from covalent species-both disulfide and nondisulfide linked, while the HMW aggregate contained a higher percentage of molecules that had the peptide bond cleavage in the CH2 domain. The dimer formed at pH - 6.0 was found to have identical secondary and tertiary structure as the intact antibody molecule. However, the dimer and higher molecular weight aggregate formed at pH - 4.0 have altered secondary and tertiary structure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18680168     DOI: 10.1002/jps.21514

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  22 in total

1.  Structure and function of purified monoclonal antibody dimers induced by different stress conditions.

Authors:  Rajsekhar Paul; Alexandra Graff-Meyer; Henning Stahlberg; Matthias E Lauer; Arne C Rufer; Hermann Beck; Alexandre Briguet; Volker Schnaible; Thomas Buckel; Sabine Boeckle
Journal:  Pharm Res       Date:  2012-04-05       Impact factor: 4.200

2.  Aggregation of a multidomain protein: a coagulation mechanism governs aggregation of a model IgG1 antibody under weak thermal stress.

Authors:  Christian Beyschau Andersen; Mauro Manno; Christian Rischel; Matthías Thórólfsson; Vincenzo Martorana
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

Review 3.  Fragmentation of monoclonal antibodies.

Authors:  Josef Vlasak; Roxana Ionescu
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

4.  Distinct aggregation mechanisms of monoclonal antibody under thermal and freeze-thaw stresses revealed by hydrogen exchange.

Authors:  Aming Zhang; Satish K Singh; Michael R Shirts; Sandeep Kumar; Erik J Fernandez
Journal:  Pharm Res       Date:  2011-07-30       Impact factor: 4.200

Review 5.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

6.  Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.

Authors:  Paolo Arosio; Simonetta Rima; Massimo Morbidelli
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

7.  Engineering a human IgG2 antibody stable at low pH.

Authors:  Seiji Saito; Hiroshi Namisaki; Keiko Hiraishi; Nobuaki Takahashi; Shigeru Iida
Journal:  Protein Sci       Date:  2020-03-18       Impact factor: 6.725

8.  Investigating Therapeutic Protein Structure with Diethylpyrocarbonate Labeling and Mass Spectrometry.

Authors:  Nicholas B Borotto; Yuping Zhou; Stephen R Hollingsworth; John E Hale; Eric M Graban; Robert C Vaughan; Richard W Vachet
Journal:  Anal Chem       Date:  2015-10-01       Impact factor: 6.986

9.  Conformational transitions provoked by organic solvents in chicken egg ovalbumin: mimicking the local environment.

Authors:  Afshin Iram; Aabgeena Naeem
Journal:  Protein J       Date:  2013-01       Impact factor: 2.371

10.  Alleviating nonlinear behavior of disulfide isoforms in the reversed-phase liquid chromatography of IgG2.

Authors:  Xiang Cao; Yan He; Jacquelynn Smith; Mary J Wirth
Journal:  J Chromatogr A       Date:  2015-08-04       Impact factor: 4.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.